CTVA vs REGN
CTVA: Corteva is a global agriculture leader specializing in advanced seed technology and crop protection solutions to support sustainable farming. REGN: Regeneron is a leading biotechnology firm that leverages its human genetics research and proprietary technology to discover and commercialize innovative therapies for serious diseases.
Side-by-side fundamentals
| Metric | CTVA | REGN | Edge |
|---|---|---|---|
| Price as of 2026-07-30 close | $89.34 | $667.17 | |
| Market cap as of 2026-08-01 | $52.6B | $62.7B | |
| P/E as of 2026-08-01 | 45.30 | 17.49 | REGN lower |
| PEG as of 2026-08-01 | 4.49 | 1.08 | REGN lower |
| Net margin as of 2026-08-01 | +6.5% | +29.6% | REGN higher |
| Gross margin as of 2026-08-01 | +48.6% | +85.7% | REGN higher |
| Operating margin as of 2026-08-01 | +15.0% | +24.3% | REGN higher |
| ROE as of 2026-08-01 | +4.7% | +14.3% | REGN higher |
| ROA as of 2026-08-01 | +2.7% | +11.1% | REGN higher |
| Debt / equity as of 2026-08-01 | 0.14 | 0.09 | REGN lower |
| Revenue growth (YoY) as of 2026-08-01 | +6.3% | +5.9% | CTVA higher |
| Revenue CAGR (3y) SEC XBRL | -0.1% | +5.6% | REGN higher |
| Dividend yield as of 2026-08-01 | +0.8% | +0.5% | CTVA higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-01 | 0.58 | 0.19 | |
| 1-year return as of 2026-07-30 close | +24.1% | +18.5% | CTVA higher |
Fundamentals: market data, as of 2026-08-01. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.